(redirected from IGFBP7)
Also found in: Dictionary, Medical, Legal, Encyclopedia.
Related to IGFBP7: IBN7, PubMed
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for PSF

a terrorist group of radical Palestinians who split with al-Fatah in 1967 but now have close relations with al-Fatah

References in periodicals archive ?
Thus far, treating HG has been ineffective and further work is required as experts look to determine whether GDF15 and IGFBP7 protein levels can safely be decreased during pregnancy to diminish symptoms.
The discovery and validation of urinary TIMP-2 and IGFBP7 as AKI biomarkers have been reviewed.
2015 Insulin-like growth IGFBP7 expression is [47] factor binding linked to protein 7 (IGFBP7) translocation t(4;14) expression showing clinical features of adverse prognosis Jung et al.
Of the biomarkers that have been established in large cohorts, 6 have shown the most promise: neutrophil gelatinase-associated lipocalin (NGAL), interleukin-18 (IL-18), kidney injury molecule 1 (KIM-1), liver fatty acid-binding protein (L-FABP), tissue inhibitor metalloproteinase inhibitor 2 (TIMP-2), and insulin growth factor-binding protein 7 (IGFBP7).
IBP7 (insulin-like growth factor-binding protein 7), coded by a gene named IGFBP7, is a protein secreted by podocytes with a possible regulatory function on cell cycle [43].
Alkuraya et al., "Mutation of IGFBP7 causes upregulation of BRAF/MEK/ERK pathway and familial retinal arterial macroaneurysms," American Journal of Human Genetics, vol.
These core-shell nanoparticles can be stabilized by an organic coating that can be pegylated for the reduction of nonspecific binding and further chemically modified for subsequent bioconjugation of the biological vehicles such as antibodies, for example, against IGFBP7 used for glioma detection [19].
In addition, a specific gene, the IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7), has been identified as under-expressed in patients compared with healthy subjects, and significantly normalized after treatment.
To date, several enzymes and biomolecules have been investigated, the most promising of which include cystatin C, neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), IL-18, liver fatty-acid binding protein (L-FABP), IL-6, [alpha]/I glutathione S-transferase (GST), N-acetyl-[beta]-D-glucosaminidase (NAG), insulin-like growth factor-binding protein 7 (IGFBP7), and tissue inhibitors of metalloproteinases-2 (TIMP-2).1,3,4
Intriguingly, our data suggested that E2 downregulated IGFBP7 (GeneID 3490) but upregulated IGF2 (GeneID 3481), which contradicted its suppressive effects in HCC.
The NephroCheck Test detects two biomarkers, urinary tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin-like growth factor binding protein 7 (IGFBP7), that increase in a patient's urine in response to the earliest kidney cell stress which, if left unmitigated, can lead to AKI.